We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

0001493152-24-023798 Sample Contracts

Clinical Trial Agreement
Clinical Trial Agreement • June 14th, 2024 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations

Clinical Trial: Phase Ib Study With The Combination Of LB–100 (PP2A Inhibitor) And Atezolizumab (PD–L1 Inhibitor) In Metastatic Colorectal Cancer Patients – The CoLBAt Trial

Standard Contracts